COVID-19 Leads to Decrease in Smoking Cessation Attempts: Study

Aug.09.2022
COVID-19 Leads to Decrease in Smoking Cessation Attempts: Study
A recent study by JAMA Network Open found that smoking cessation attempts decreased by 2.9% in 2020, attributed to the spread of COVID-19 in the US.

According to a recent study by JAMA Network Open, the number of individuals attempting to quit smoking decreased by 2.9% in 2020 compared to 2019. The study attributed this decline to the spread of COVID-19 in the United States. This finding was part of a 10-year study tracking nearly 800,000 people who reported smoking daily or for most of the week. The largest decrease in quit attempts occurred in April, May, and June of 2020, with a 3.4% decline compared to the same period in 2019. However, the number of successful quitters has significantly increased since 2011.


The study also examined the sales of nicotine replacement therapies such as gum, lozenges, and patches. These products saw a 13% decrease in sales in 2020 compared to expected sales, and the decline continued into early 2021. However, sales started to recover in April, May, and June of 2021.


The findings of this study align with those of a smoking cessation hotline. According to data from the North American Quitline Consortium, demand for smoking cessation services declined from February to June of 2020 and continued on a downward trend in 2021 until March and April, when demand returned to pre-pandemic levels.


A recent study contradicts a commentary in BMJ Open earlier this year, suggesting that smoking during the COVID-19 pandemic may actually increase the likelihood of quitting. The study examined smokers, e-cigarette users, and those who used both nicotine products. Those who only smoked felt a higher risk of getting infected with COVID-19 and therefore were more motivated to quit. The study suggests that if smokers were made aware of the increased susceptibility to disease caused by smoking, they would be more likely to quit, particularly if they were older.


On the other hand, research has found an increase in the use of electronic cigarettes during the COVID-19 pandemic. These users perceive electronic cigarettes as less harmful and potentially a substitute for traditional cigarettes, leading to a lower likelihood of quitting smoking during the pandemic. The study also found that those who use both cigarettes and electronic cigarettes tend to purchase more cigarettes, further increasing their usage.


Statement


This article is compiled from third-party information and is for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and they cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in the level of translation, the translated article may not fully convey the intended meaning of the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in regards to any domestic, Hong Kong/Macau/Taiwan-related, or foreign statements and positions.


The compiled information is copyrighted to the original media and author. If there is infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary resigned on May 12 after opposing the Trump administration’s push to authorize fruit-flavored vaping products, according to reporting by The New York Times. Makary reportedly objected over concerns that flavored vapes could attract young people and refused to support broader approvals.
News
May.13
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
According to Bloomberg, Philip Morris International’s Zyn is facing growing competition in the U.S. nicotine pouch market as consumers shift toward moister alternatives such as British American Tobacco’s Velo Plus.
BATPMI
May.22
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s Department of Disease Control has warned the public not to believe claims that nicotine pouches are harmless, saying the products contain high levels of nicotine that can enter the bloodstream through the mouth lining and affect the nervous system and brain.
Apr.30 by 2FIRSTS.ai
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
The UK government plans to expand police and trading standards powers by extending closure orders for shops selling illegal vapes and cigarettes from a maximum of six months to 12 months, in a crackdown on organised crime on high streets.
Jun.12
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
The U.S. Food and Drug Administration issued guidance on May 8, 2026, titled “Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization.” The document describes FDA enforcement policies for certain electronic nicotine delivery system products and nicotine pouch products marketed without premarket authorization.
May.09 by 2FIRSTS.ai